The NFL denied Brendan Sorsby's request for entry into the supplemental draft in 2026. Here is the full letter sent to Sorsby ...
This joint-specific response pattern was consistent across all advanced treatment modalities, including abatacept, interleukin-6 receptor inhibitors, Janus kinase inhibitors, rituximab and TNFi.